logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

RegorafenibMyasthenia gravis: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1953卷 / 1期
关键词:
D O I:
10.1007/s40278-023-37785-9
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:350 / 350
相关论文
共 50 条
  • [31] PembrolizumabMyasthenia gravis: case report
    Reactions Weekly, 2017, 1662 (1) : 293 - 293
  • [32] DurvalumabMyasthenia gravis: case report
    Reactions Weekly, 2024, 2029 (1) : 244 - 244
  • [33] IpilimumabMyasthenia gravis: case report
    Reactions Weekly, 2018, 1701 (1) : 165 - 165
  • [34] PembrolizumabMyasthenia gravis: case report
    Reactions Weekly, 2019, 1764 (1) : 268 - 268
  • [35] ElasomeranMyasthenia gravis: case report
    Reactions Weekly, 2022, 1929 (1) : 271 - 271
  • [36] PembrolizumabMyasthenia gravis: case report
    Reactions Weekly, 2021, 1878 (1) : 434 - 434
  • [37] AlemtuzumabMyasthenia gravis: case report
    Reactions Weekly, 2020, 1802 (1) : 21 - 21
  • [38] PembrolizumabMyasthenia gravis: case report
    Reactions Weekly, 2017, 1650 (1) : 226 - 226
  • [39] MacitentanMyasthenia gravis : case report
    Reactions Weekly, 2024, 2017 (1) : 272 - 272
  • [40] PembrolizumabMyasthenia gravis: case report
    Reactions Weekly, 2020, 1787 (1) : 412 - 412
← 12345 →